News

Dr. Reddy's Laboratories Ltd. closed 17.37% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...
The leading pharmaceutical major has denied ‘factually incorrect’ media reports claiming it plans to cut workforce costs by ...
Dr. Reddy's Laboratories Ltd. closed 15.40% below its 52-week high of 1,420.20 rupees, which the company reached on August ...
A report claimed that employees in the age group of 50-55 years working in Dr Reddy’s research and development (R&D) division ...
Discover the Dr Reddys Stock Liveblog, your ultimate resource for real-time updates and insightful analysis on a prominent ...
Dr. Reddy's Laboratories, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1186.35. The stock has experienced fluctuations today ...
We recently published a list of the 10 Best Indian Stocks to Buy According to Billionaires. In this article, we will take a ...
FY24 annual report shows it had over 26,000 employees worldwide as of March 2024. That includes 21,757 permanent staff. In ...
Dr. Reddy's Laboratories (NYSE:RDY) has denied reports that the company will be laying off its workforce to cut labor costs ...
Additionally, some employees in the 50-55 age bracket, primarily within the research and development division, have been ...
The rumours of mass resignations and cost slashing at Dr. Reddy’s appear to be just that—rumours. With official clarification ...
Stay updated with the latest news on Dr Reddy's Laboratories. Explore breaking news headlines about Dr Reddy's Laboratories and more ...